Andrea Necchi, Joep de Jong, James A. Proudfoot, Brigida Anna Maiorano, Antonio Cigliola, Valentina Tateo, Chiara Mercinelli, Michela Ravasi, Elai Davicioni, Marco Moschini, Giorgio Brembilla, Maurizio Colecchia, Francesco De Cobelli, Alberto Briganti, Francesco Montorsi. "First results of SURE-02: A phase 2 study of neoadjuvant sacituzumab govitecan (SG) plus pembrolizumab (Pembro), followed by response-adapted bladder sparing and adjuvant pembro, in patients with muscle-invasive bladder cancer (MIBC).." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.4518